Author

Shiwei Wang

Peking UniversityORCID 0000-0003-2175-1156Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Shiwei Wang5 papers · Broad Institute

Biology Disciplines

Click to filter author papers

Bioinformatics· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:database / resource· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:protein structure· 1 Approach:statistical model· 1

Frequent Co-Authors

Jianfeng PeiiD· 2 shared Luhua LaiiD· 2 shared Youjun XuiD· 2 shared Haoyu LiniD· 1 shared Qi SuniD· 1 shared Xiaobing Deng· 1 shared Yufeng HeiD· 1 shared Zhixian HuangiD· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioinformatics

Jianfeng PeiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioinformaticsBiomoleculesPeer-reviewedJul 11, 2022

CavitySpace: A database of potential ligand binding sites in the human proteome

Shiwei Wang, Haoyu Lin, Zhixian Huang…·Luhua Lai

CavitySpace identifies potential ligand binding sites in the human proteome using predicted structures, aiding in drug design and function prediction.

39 citationstop 3%

humanprotein structure

𝕏 PostBluesky

BioinformaticsBriefings in BioinformaticsPeer-reviewedMay 14, 2021

A Transferable Deep Learning Approach to Fast Screen Potent Antiviral Drugs against SARS-CoV-2

Shiwei Wang, Qi Sun, Youjun Xu…·Luhua Lai

The paper develops a deep learning model to screen antiviral drugs against SARS-CoV-2, identifying a novel compound with promising inhibitory activity.

52 citationstop 3%

deep learningdrug response / drug discovery

𝕏 PostBluesky